Validated. Safe.
Interview with Marc Plevschinksi, Managing Director of Normec Valitech GmbH & Co. KG
Validation might sound technical, but it is a central element for safety and trust in healthcare. Normec Valitech GmbH & Co. KG in Falkensee ensures through independent testing procedures that the reprocessing of medical instruments meets the highest hygienic standards. Managing Director Marc Plevschinksi explains how the company has developed into an internationally sought-after complete provider with innovative strength and foresight.
Wirtschaftsforum: Mr. Plevschinski, the term 'validation' sounds technical and abstract. Why is it so central to our healthcare system nonetheless?
Marc Plevschinski: Because validation is the neutral proof that the reprocessing of medical instruments works reliably. In dental offices, clinics, or laboratories, instruments must be germ-free after each use – in the interest of both patients and staff. Validation secures this hygiene chain. It checks with clear guidelines and independent procedures: Are all prescribed processes being followed? Are the temperature, pressure, and cleaning efficacy correct? In short: Is the reprocessing safe?
Wirtschaftsforum: So, it essentially concerns infection protection?
Marc Plevschinski: Exactly. Our work is a part of infection prevention. What we provide is trust: for operators, for patients, for authorities. The legally required proof is sensible and justified. We ensure that it can be provided precisely, transparently, and with minimal effort for the operator.
Wirtschaftsforum: What was the origin of Normec Valitech, and how has your role in the company developed?
Marc Plevschinski: Our founder Thorsten Große recognized the need for independent testing services as early as 1995 with the implementation of the Medical Device Act. Normec Valitech started as a small engineering office for validations and gradually evolved: with its own chemical and microbiological laboratories, self-developed measuring technology and data loggers. I myself started in 2014 as a validator, later took over the management of the laboratory, became authorized signatory in 2022, and have been the managing director since 2024. I am fascinated by the combination of technology, science, and contributing to health.
Wirtschaftsforum: What sets Normec Valitech apart from the competition, and what benefit do customers derive from this?
Marc Plevschinski: We offer everything from a single source: Our self-trained validators work with high-precision data loggers, which we develop and manufacture in-house. In addition, we have an accredited laboratory for chemical and microbiological analyses. This combination of independence and technical depth, from data collection to laboratory analysis, is unique. Our customers benefit from quality and reliability: we have everything in sight, everything under control. In addition, they benefit from efficiency. Our processes are well-thought-out, our team is excellently coordinated. We schedule appointments proactively, guiding the customer literally by the hand, from preparation to the debriefing of the report. We ensure that validation is experienced as a true security gain, not as a bureaucratic obligation.
Wirtschaftsforum: What are the current growth opportunities for Normec Valitech – both nationally and internationally?
Marc Plevschinski: Internationally, we rely on our own developed data loggers, which can be used worldwide – anywhere parameters such as pressure or temperature need to be monitored. We are in discussions with partners in the Czech Republic, Turkey, France, or Scandinavia and also see potential at Asian trade fairs. In Germany, we focus on digitalization and new application fields, such as in the food industry or air quality testing in public buildings, a topic that has gained significant importance since the pandemic. Thanks to our microbiological expertise, we can offer targeted solutions here. Additionally, as part of the Normec Group, we benefit from synergies with other testing and inspection specialists. This strengthens our innovation power and our international networking.
Wirtschaftsforum: In many industries, there is a shortage of skilled workers. How do you address this?
Marc Plevschinski: Our employees are our most important asset. We have about 100 employees, many of whom are in field service or home office. For us, the key lies in transparency, participation, and communication, also through digital platforms. We invest heavily in exchange and cooperation. This is the only way to create identification and long-term commitment – not only among customers but also within the team.
Wirtschaftsforum: What is the focus for Normec Valitech in the coming years?
Marc Plevschinski: We want to further develop our existing business model: new data loggers for more applications, validations in new industries, stronger international presence. At the same time, we would like to participate in expert committees and in the development of standards, as our practical experience can help make new regulations more practical. And we want to continue to be a reliable, innovation-driven partner, for more safety, more hygiene, and less bureaucracy in the daily lives of our customers.